Literature DB >> 3497227

Dominantly inherited Alzheimer's disease: cerebral glucose metabolism.

R J Polinsky, H Noble, G Di Chiro, L E Nee, R G Feldman, R T Brown.   

Abstract

Cerebral glucose metabolic rate (CMRGlu), measured by positron emission tomography, was bilaterally and symmetrically reduced in two patients with autosomal dominant Alzheimer's disease. Supramarginal gyri and temporal lobes were most severely affected. An isolated reduction of CMRGlu in the left supramarginal gyrus was observed in one asymptomatic at-risk subject.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3497227      PMCID： PMC1032083          DOI： 10.1136/jnnp.50.6.752

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  28 in total

1.  ALZHEIMER'S PRESENILE DEMENTIA. A HISTOCHEMICAL AND ELECTRON MICROSCOPIC STUDY.

Authors:  M R KRIGMAN; R G FELDMAN; K BENSCH
Journal:  Lab Invest       Date:  1965-04       Impact factor: 5.662

2.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

3.  A family with histologically confirmed Alzheimer's disease.

Authors:  L E Nee; R J Polinsky; R Eldridge; H Weingartner; S Smallberg; M Ebert
Journal:  Arch Neurol       Date:  1983-04

4.  Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease.

Authors:  M J de Leon; S H Ferris; A E George; B Reisberg; D R Christman; I I Kricheff; A P Wolf
Journal:  J Cereb Blood Flow Metab       Date:  1983-09       Impact factor: 6.200

5.  Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography.

Authors:  R S Frackowiak; C Pozzilli; N J Legg; G H Du Boulay; J Marshall; G L Lenzi; T Jones
Journal:  Brain       Date:  1981-12       Impact factor: 13.501

6.  Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method.

Authors:  M E Phelps; S C Huang; E J Hoffman; C Selin; L Sokoloff; D E Kuhl
Journal:  Ann Neurol       Date:  1979-11       Impact factor: 10.422

7.  Positron emission tomographic studies of aging and Alzheimer disease.

Authors:  M J de Leon; S H Ferris; A E George; D R Christman; J S Fowler; C Gentes; B Reisberg; B Gee; M Emmerich; Y Yonekura; J Brodie; I I Kricheff; A P Wolf
Journal:  AJNR Am J Neuroradiol       Date:  1983 May-Jun       Impact factor: 3.825

8.  Regional correlation of PET and CT in senile dementia of the Alzheimer type.

Authors:  M J de Leon; A E George; S H Ferris; S Rosenbloom; D R Christman; C I Gentes; B Reisberg; I I Kricheff; A P Wolf
Journal:  AJNR Am J Neuroradiol       Date:  1983 May-Jun       Impact factor: 3.825

9.  Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose.

Authors:  R P Friedland; T F Budinger; E Ganz; Y Yano; C A Mathis; B Koss; B A Ober; R H Huesman; S E Derenzo
Journal:  J Comput Assist Tomogr       Date:  1983-08       Impact factor: 1.826

10.  Alzheimer's disease: focal cortical changes shown by positron emission tomography.

Authors:  N L Foster; T N Chase; P Fedio; N J Patronas; R A Brooks; G Di Chiro
Journal:  Neurology       Date:  1983-08       Impact factor: 9.910
View more
  3 in total

1.  FFT approximation in Alzheimer's disease.

Authors:  C Fornara; M Cursi; L Roveri; F Minicucci; T Locatelli; G Comi
Journal:  Ital J Neurol Sci       Date:  1998-08

2.  The earliest cognitive change in a person with familial Alzheimer's disease: presymptomatic neuropsychological features in a pedigree with familial Alzheimer's disease confirmed at necropsy.

Authors:  S K Newman; E K Warrington; A M Kennedy; M N Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

3.  Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease.

Authors:  Tammie L S Benzinger; Tyler Blazey; Clifford R Jack; Robert A Koeppe; Yi Su; Chengjie Xiong; Marcus E Raichle; Abraham Z Snyder; Beau M Ances; Randall J Bateman; Nigel J Cairns; Anne M Fagan; Alison Goate; Daniel S Marcus; Paul S Aisen; Jon J Christensen; Lindsay Ercole; Russ C Hornbeck; Angela M Farrar; Patricia Aldea; Mateusz S Jasielec; Christopher J Owen; Xianyun Xie; Richard Mayeux; Adam Brickman; Eric McDade; William Klunk; Chester A Mathis; John Ringman; Paul M Thompson; Bernardino Ghetti; Andrew J Saykin; Reisa A Sperling; Keith A Johnson; Stephen Salloway; Stephen Correia; Peter R Schofield; Colin L Masters; Christopher Rowe; Victor L Villemagne; Ralph Martins; Sebastien Ourselin; Martin N Rossor; Nick C Fox; David M Cash; Michael W Weiner; David M Holtzman; Virginia D Buckles; Krista Moulder; John C Morris
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-05       Impact factor: 11.205
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.